GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Pre-Tax Income

Longevity Biomedical (Longevity Biomedical) Pre-Tax Income : $ Mil (TTM As of . 20)


View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Longevity Biomedical's pretax income for the six months ended in . 20 was $0.00 Mil. Longevity Biomedical does not have enough years/quarters to calculate the pretax income for the trailing twelve months (TTM) ended in . 20. Longevity Biomedical's pretax margin was %.


Longevity Biomedical Pre-Tax Income Historical Data

The historical data trend for Longevity Biomedical's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical Pre-Tax Income Chart

Longevity Biomedical Annual Data
Trend
Pre-Tax Income

Longevity Biomedical Semi-Annual Data
Pre-Tax Income

Competitive Comparison of Longevity Biomedical's Pre-Tax Income

For the Biotechnology subindustry, Longevity Biomedical's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Longevity Biomedical's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longevity Biomedical's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Longevity Biomedical's Pre-Tax Income falls into.



Longevity Biomedical Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Longevity Biomedical's Pretax Income for the fiscal year that ended in . 20 is calculated as

Longevity Biomedical's Pretax Income for the quarter that ended in . 20 is calculated as


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Longevity Biomedical  (NAS:LBIO) Pre-Tax Income Explanation

Longevity Biomedical's Pretax Margin for the quarter that ended in . 20 is calculated as

Pretax Margin=Pretax Income/Revenue
=/
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Longevity Biomedical Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Longevity Biomedical (Longevity Biomedical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines